Acute Coronary Syndromes in Human Immunodeficiency Virus Patients: A Meta-Analysis Investigating Adverse Event Rates and the Role of Antiretroviral Therapy

Study Questions:

Highly active antiretroviral therapy (HAART) dramatically reduces human immunodeficiency virus (HIV)-associated morbidity and mortality, but adverse effects of HAART are becoming an increasing challenge, especially in the setting of acute coronary syndromes (ACS). What is the impact of HAART on ACS in HIV patients?